QID 730670

Date Published: 2023-02-07

QID 730670: Oracle E-Business Suite Multiple Security Vulnerabilities (CPUOCT2022)

Oracle E-Business Suite is one of Oracle Corp.'s major product lines. Also known as Oracle EBS, it is an integrated set of business applications for automating customer relationship management (CRM), enterprise resource planning (ERP) and supply chain management (SCM) processes within organizations.

Oracle E-Business Suite contains an unspecified vulnerability that allows an unauthenticated attacker with network access via HTTP to compromise Oracle Web Applications Desktop Integrator.

Affected Products:
Oracle E-Business Suite versions 12.2.3 - 12.2.11

QID Detection Logic (Unauthenticated):
Detection would be overwriting existing perl file "txkfndwrr.pl" using vulnerable endpoint "OA_HTML/BneViewerXMLService?bne:uueupload=TRUE" with malicious payload and on successful execution, uploaded payload will echo string "QualysTest: File has been modified for QID 730670 (CVE-2022-21587)" in response over endpoint "OA_CGI/FNDWRR.exe".

NOTE:
Qualys recommends to create a backup of the file -"txkFNDWRR.pl" present at path - "FMW_Home/Oracle_EBS-app1/common/scripts/" before scanning.

Successfully exploitation of these vulnerabilities may allow an unauthenticated attacker to execute arbitrary code on the target system.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as High - 7.5 severity.
    • Solution
    Refer to vendor advisory Oracle E-Business Suite OCTOBER 2022.
    Vendor References

    CVEs related to QID 730670

    CVE-2022-21587 | CVE-2022-39428 |
    Software Advisories
    Advisory ID Software Component Link
    cpuoct2022 URL Logo www.oracle.com/security-alerts/cpuoct2022.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].